Ligand id: 7995

Name: racotumomab

Compound class Antibody
Approved drug? Yes
International Nonproprietary Names
INN number INN
8998 racotumomab
1E10 | Vaxira®
Racotumomab is an anti-idiotype therapeutic cancer vaccine directed against the ganglioside N-glycolil (NGc) GM3, which has been identified on the cell surface of malignant cells from lung [3] and breast tumours [6], melanoma [8-9], and neuroectodermal pediatric tumours [4-5,10-11]. Racotumomab is being investigated for its antineoplastic activity.
Annotated peptide sequences for this antibody are available from its IMGT/mAb-DB record.
Database Links
Specialist databases
IMGT/mAb-DB 225
Other databases
GtoPdb PubChem SID 249565675
Search PubMed clinical trials racotumomab
Search PubMed titles racotumomab
Search PubMed titles/abstracts racotumomab
Wikipedia Racotumomab